SavedAdd your journal

Journals / ENTcase / 2019 / Cilt: 5 - Sayı: 4

COMBINATION THERAPY OF SHAVE EXCISION, INTRALESIONALSTEROID INJECTION, AND TOPICAL IMIQUIMOD IN THETREATMENT OF EAR KELOID

Süha ERTUĞRUL
Habibullah AKTAŞ
Gökşen ERTUĞRUL
Journal
ENTcase
Pages
155–158
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Within one year, a verygood response was obtained without recurrence or anyside effect.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Keloids are benign proliferative lesions caused byabnormal healing.
📊
Key Findings & Data:Treatment of keloids is verydifficult due to high recurrence rates.
💡
Conclusion & Impact:Within one year, a verygood response was obtained without recurrence or anyside effect.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Keloids are benign proliferative lesions caused byabnormal healing. Treatment of keloids is verydifficult due to high recurrence rates. In keloids, thereare many treatment modalities that can vary accordingto lesion size, localization, and previous interventions.A 17-year-old female patient presented with aposterior ear keloid that developed after pearcing intoher ear. The shaving excision was treated with a triplecombination consisting of single session intralesionalsteroidinjectionanddailytopicalimiquimodapplication for six weeks. Within one year, a verygood response was obtained without recurrence or anyside effect.

🔖

Cite This Article

ERTUĞRUL, S., AKTAŞ, H., ERTUĞRUL, G. (2019). COMBINATION THERAPY OF SHAVE EXCISION, INTRALESIONALSTEROID INJECTION, AND TOPICAL IMIQUIMOD IN THETREATMENT OF EAR KELOID. ENTcase, Cilt: 5 - Sayı: 4, 155–158. https://ajindex.com/articles/152175

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Goder M, et al.Cutaneous basal cell carcinoma arising within a keloid scar: a case report. Onco TargetsTher. 2016;9:4793-6. 2.Watson D, Panuganti B. Treating Scars in the Auricle Region. Facial Plast Surg Clin Nort Am.2017;25(1):73-81. 3. Jacob SE, et al. Topical application of imiquimod 5% cream to keloids alters expression genes associatedwith apoptosis. Br J Dermatol. 2003;66:62-5. 4.Berman B, Kaufman J. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrencerate of excised keloids. J Am Acad Dermatol. 2002;47(4 Suppl):S209-11. 5.Stashower ME. Successful treatment of earlobe keloids with imiquimod after tangential shave excision.Dermatol Surg. 2006;32(3):380-6. 6.Martin-Garcia RF, Busquets AC. Postsurgical use of imiquimod 5% cream in the prevention of earlobekeloid recurrences: results of an open-label, pilot study. Dermatol Surg. 2005;31(11):1394-8. 7.Cação FM, Tanaka V, Messina MC. Failure of imiquimod 5% cream to prevent recurrence of surgicallyexcised trunk keloids. Dermatol Surg. 2009;35(4):629-33. 8.Ragoowansi R, Cornes PG, Moss AL, Glees JP. Treatment of keloids by surgical excision and immediatepostoperative single-fraction radiotherapy. Plast Reconstr Surg. 2003;111(6):1853-9. 9.Liu CL, Yuan ZY. Retrospective study of immediate postoperative electron radiotherapy for therapy-resistant earlobe keloids. Arch Dermatol Res. 2019;311(6):469-475. 10.Horton CE, Crawford J, Oakey RS. Malignant change in keloids. Plast Reconstr Surg. 1953l;12(1):86-9.